Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Cancer research institute
May 12, 2024, 15:20 |
Blog
David Feinberg: Proactive interventions are almost always more effective than reactive care delivery
Karen Knudsen shared a post by David Feinberg, Chief Executive Officer at Cerner Corporation, on LinkedIn…
May 12, 2024, 13:30 |
Blog
Biagio Ricciuti: Insightful discussions at Rome Lung 24
Biagio Ricciuti shared a post by Stephen Liu on X and added: "Had a great…
May 12, 2024, 08:29 |
Insight
Valerie Yang: The critical need for healthcare providers identifies mental health concerns
Valerie Yang, Assistant Professor at Duke-NUS Medical School, shared on LinkedIn: "Hot Off The Press…
May 12, 2024, 07:56 |
Dialogues
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Join us for an exciting new episode of “OncoInfluencers”, hosted by Dr. Gevorg Tamamyan. In this episode, we…
May 12, 2024, 03:12 |
Blog
Misty Dawn Shields: Groundbreaking study challenging the dogma of 'YAP1' neuroendocrine subtype in SCLC
Misty Dawn Shields, Assistant Professor of Clinical Medicine, Division of Hematology/Oncology at IU School of…
May 11, 2024, 13:48 |
Blog
Karen Knudsen: All hands on deck at MIGlobal
Karen Knudsen shared on LinkedIn: "All hands on deck at MIGlobal, toward the goal of improving…
May 11, 2024, 13:41 |
Blog
Jorge Reis-Filho: A great opportunity to learn more about the exciting work being done at AstraZeneca
Jorge Reis-Filho, Vice President, Cancer Biomarker Development at AstraZeneca, shared a post by Diana Merino…
May 11, 2024, 11:39 |
Blog
Julia Maués: HER2-positive, HER2-low, HER2-shy
Julia Maués, Co-Founder of Grasp Cancer, shared a post by Paolo Tarantino on X and…
May 11, 2024, 11:23 |
Insight
Matt Sagan: Moving from HER2+ to HER2-low to HER2- ultralow
Matt Sagan, Co-Founder and CEO of FiBioMed, shared a post by Paolo Tarantino on X,…
May 11, 2024, 10:48 |
Blog
David Sebag-Montefiore: From the CRUK RadNet Leeds renewal interview to the ESTRO 2024 annual meeting
David Sebag-Montefiore shared on LinkedIn: “It's been a very exciting week! From the CRUK RadNet Leeds…
216
217
218
219
220
All:
2775
Posts:
2171 - 2180
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube